Hannah Brown credits GLP-1 for PMOS relief
Key takeaways
- Hannah Brown recalled a conversation with co-host Dr.
- Aliabadi introduced her to the treatment, stating, ‘You were the first to tell me even what a GLP-1 was and how it could help with my insulin resistance.’
- According to the Cleveland Clinic, GLP-1 receptor agonists like Ozempic and Mounjaro aid in the management of type 2 diabetes and obesity.
Why this matters: local context for readers following news across Pakistan and the region.
Add ARY News on Google AAResize In a recent appearance on the She MD podcast, former Bachelorette star Hannah Brown opened up about her journey with polyendocrine metabolic ovarian syndrome (PMOS) and disclosed that she was prescribed a GLP-1 medication to treat the condition.
Hannah Brown recalled a conversation with co-host Dr. Thaïs Aliabadi, saying, ‘You had discussed me going on a GLP-1. We talked about the weight gain that I was having.’ She added, ‘I was obviously really bloated. I was not having my period. You know, it would be every three months—maybe I would have one for two days and then that would be it.’
Brown noted that Dr. Aliabadi introduced her to the treatment, stating, ‘You were the first to tell me even what a GLP-1 was and how it could help with my insulin resistance.’